Skip to main content

Alexion To Acquire Achillion Pharma For $930M

Alexion Pharma will buy Achillion Pharma for the initial value of $930 million, or $6.30 per share in cash plus added contingent considerations for a total potential value of $8.30 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.